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STI-pathogens as predisposing factors for
acquisition and transmission of HIV
O.I. Olayinka
BABCOCK UNIVERSITY, Ilisan Remo, Nigeria
Background: STIs associated with hepatitis B and C, genital
warts and herpes, T. vaginalis infections of Chlamydia tra-
chomatis,Nessieria gonorrhoeae and even candidiasis enhance the
acquisition and transmission of HIV. This has implication for early
diagnosis and intensifyingpublic health surveillance as well as
planning control programmes.
Methods & Materials: Here, we collected urine and vagina
swabs using sterile universal bottles and Evapon swab sticks
respectively from 100 females of which 34 were HIV-positive and
66 HIV- negative. The samples were screened for the presence of
Trichomonas vaginalis,Candida albicans, pus cells andbacterial vagi-
nosis.
Results: Twelve percent of HIV-positive patients were infected
with T. vaginalis, 77% with C. albicans, 68% with bacterial vaginosis
and 35% with pus cells (indicates the presence of cervical infec-
tions). Only 2% of the HIV-negative patients were infected with T.
vaginalis 20% with C. albicans, 40% with bacterial vaginosis and 5%
with pus cells. The statistical analysis showed a signiﬁcant differ-
ence in the infection rates between HIV infected and non- infected
patients (p <0.05).
Conclusion: Since STIs are not only associated with their own
morbidity, but also facilitate sexual transmission and infectivity of
HIV, there is therefore the need for aggressive prevention, testing
and treatment of STIs in order to reduce acquisition and transmis-
sion of HIV.
http://dx.doi.org/10.1016/j.ijid.2014.03.702
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Antiretroviral induced adverse drug reactions
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Background: To our knowledge, there is a rare report regarding
antiretroviral induced adverse drug reactions (ADRs) in Malian
patients who were infected with the human immunodeﬁciency
virus (HIV).Wehave evaluated the frequency of antiretroviral ther-
apy (ART) induced ADRs in this population and have assessed some
risk factors of these reactions.
Methods & Materials: This is a prospective cohort study that
was performed in the Human Immunodeﬁciency Virus/Acquired
ImmuneDeﬁciency SyndromeResearch Center (The CESAC) ofMali
during years 2010–2011. Adults patients, who were infected with
HIV and newly started on ART, were included in this study and
by laboratory and clinical follow-up was performed for at least
6 months to detect the occurrence of any ADR. Naranjo’s scale of
classiﬁcation has been used to characterize the side effects.
Results: During this study 94.6% of patients showed at least
one ADR and 5.3% at least two ADRs. Prevalence of ADRs based
on affected organwas 3.1% gastrointestinal (GI), 15.4% hematologi-
cal, 45.9% neurological, 10.6% cutaneous, 1.4% hepatic, and 20.4%
metabolic adverse effects. Adverse events were highly probable
according to the Naranjo score (83.7%).The use of Zidovudine and
Stavudine was observed as risk factors for anaemia, and periph-
eral neuropathy,and lipodystrophy, respectively, while nevirapine
and female gender were identiﬁed as risk factors for skin reactions,
lipohypertrophy by bivariate logistic regression.
Conclusion: Side effects were frequently encountered in our
study. The nature of these adverse events was mostly periph-
eral neuropathy, lipoatrophy, lipodystrophy, and anemia. The
link between the use of antiretroviral drugs and adverse events
was highly probable according to the Naranjo probability scale.
We recommend an active clinical and laboratory monitoring of
antiretroviral therapy to strengthen pharmacovigilance in Mali.
http://dx.doi.org/10.1016/j.ijid.2014.03.703
